procoloran
Amgen signs Servier deal
July 11, 2013Sales and Marketing Amgen, Servier, heart, procoloran
Amgen has gained rights in the US to two of Servier’s heart drugs: the novel, oral Procoralan and investigational Phase …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
